» Articles » PMID: 15824318

Mutations in PTEN-induced Putative Kinase 1 Associated with Recessive Parkinsonism Have Differential Effects on Protein Stability

Overview
Specialty Science
Date 2005 Apr 13
PMID 15824318
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Several mutations in PTEN-induced putative kinase 1 (PINK1) gene have been reported to be associated with recessive parkinsonism. The encoded protein is predicted to be a Ser/Thr protein kinase targeted to mitochondria. In this study, we have investigated the effects of mutations on PINK1 kinase activity in vitro and on expression levels and localization in mammalian cells. We chose to examine two point mutations: G309D, which was originally reported to be stable and properly localized in cells and L347P, which is of interest because it is present at an appreciable carrier frequency in the Philippines. We were able to confirm kinase activity and produce artificial "kinase-dead" mutants that are stable but lack activity. The L347P mutation grossly destabilizes PINK1 and drastically reduces kinase activity, whereas G309D has much more modest effects on these parameters in vitro. This finding is in line with predictions based on homology modeling. We also examined the localization of PINK1 in transfected mammalian cells by using constructs that were tagged with myc or GFP at either end of the protein. These results show that PINK1 is processed at the N terminus in a manner consistent with mitochondrial import, but the mature protein also exists in the cytosol. The physiological relevance of this observation is not yet clear, but it implies that a portion of PINK1 may be exported after processing in the mitochondria.

Citing Articles

The tumor suppressor Parkin exerts anticancer effects through regulating mitochondrial GAPDH activity.

Sun X, Ye G, Li J, Yuan L, Bai G, Xu Y Oncogene. 2024; 43(44):3215-3226.

PMID: 39285229 DOI: 10.1038/s41388-024-03157-3.


Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an alzheimer disease animal model.

Yi J, Wang H, Lu G, Zhang H, Wang L, Li Z Autophagy. 2024; 20(12):2655-2676.

PMID: 39051473 PMC: 11587853. DOI: 10.1080/15548627.2024.2383145.


Cdk8/CDK19 promotes mitochondrial fission through Drp1 phosphorylation and can phenotypically suppress pink1 deficiency in Drosophila.

Liao J, Chung H, Shih C, Wong K, Dutta D, Nil Z Nat Commun. 2024; 15(1):3326.

PMID: 38637532 PMC: 11026413. DOI: 10.1038/s41467-024-47623-8.


Comparative analysis of primate and pig cells reveals primate-specific PINK1 expression and phosphorylation.

Chen X, Han R, Liu Y, Huang W, Wang Q, Xiong X Zool Res. 2024; 45(2):242-252.

PMID: 38287905 PMC: 11017073. DOI: 10.24272/j.issn.2095-8137.2023.241.


A PINK1 input threshold arises from positive feedback in the PINK1/Parkin mitophagy decision circuit.

Waters C, Angenent S, Altschuler S, Wu L Cell Rep. 2023; 42(10):113260.

PMID: 37851575 PMC: 10668033. DOI: 10.1016/j.celrep.2023.113260.


References
1.
Khan N, Valente E, Bentivoglio A, Wood N, Albanese A, Brooks D . Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol. 2002; 52(6):849-53. DOI: 10.1002/ana.10417. View

2.
Scherfler C, Khan N, Pavese N, Eunson L, Graham E, Lees A . Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain. 2004; 127(Pt 6):1332-42. DOI: 10.1093/brain/awh150. View

3.
Rohe C, Montagna P, Breedveld G, Cortelli P, Oostra B, Bonifati V . Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol. 2004; 56(3):427-31. DOI: 10.1002/ana.20247. View

4.
Unoki M, Nakamura Y . Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene. 2001; 20(33):4457-65. DOI: 10.1038/sj.onc.1204608. View

5.
Baptista M, OFarrell C, Daya S, Ahmad R, Miller D, Hardy J . Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem. 2003; 85(4):957-68. DOI: 10.1046/j.1471-4159.2003.01742.x. View